Per accedir als documents amb el text complet, si us plau, seguiu el següent enllaç: http://hdl.handle.net/2445/104263
dc.contributor | Universitat de Barcelona |
---|---|
dc.contributor.author | Montraveta, Arnau |
dc.contributor.author | Lee-Vergés, Eriong |
dc.contributor.author | Roldán, Jocabed |
dc.contributor.author | Jiménez, Laura |
dc.contributor.author | Cabezas, Sandra |
dc.contributor.author | Clot, Guillem |
dc.contributor.author | Pinyol, Magda |
dc.contributor.author | Xargay i Torrent, Sílvia |
dc.contributor.author | Rosich, Laia |
dc.contributor.author | Arimany Nardi, Cristina |
dc.contributor.author | Aymerich Gregorio, Marta |
dc.contributor.author | Villamor i Casas, Neus |
dc.contributor.author | López Guillermo, Armando |
dc.contributor.author | Pérez-Galán, Patricia |
dc.contributor.author | Roué, Gaël |
dc.contributor.author | Pastor Anglada, Marçal |
dc.contributor.author | Campo Güerri, Elias |
dc.contributor.author | López Guerra, Mónica |
dc.contributor.author | Colomer Pujol, Dolors |
dc.date | 2016-11-29T12:36:03Z |
dc.date | 2016-11-29T12:36:03Z |
dc.date | 2015-12-19 |
dc.date | 2016-11-29T12:36:08Z |
dc.identifier.citation | 1949-2553 |
dc.identifier.citation | 656888 |
dc.identifier.uri | http://hdl.handle.net/2445/104263 |
dc.format | 14 p. |
dc.format | application/pdf |
dc.language.iso | eng |
dc.publisher | Impact Journals |
dc.relation | Reproducció del document publicat a: https://doi.org/10.18632/oncotarget.6685 |
dc.relation | Oncotarget, 2015, vol. 7, num. 5, p. 5507-5520 |
dc.relation | https://doi.org/10.18632/oncotarget.6685 |
dc.rights | cc-by (c) Montraveta, Arnau et al., 2015 |
dc.rights | info:eu-repo/semantics/openAccess |
dc.rights | http://creativecommons.org/licenses/by/3.0/es |
dc.subject | Leucèmia limfocítica crònica |
dc.subject | Limfomes |
dc.subject | Quimioteràpia |
dc.subject | Marcadors bioquímics |
dc.subject | Medicaments |
dc.subject | Chronic lymphocytic leukemia |
dc.subject | Lymphomas |
dc.subject | Chemotherapy |
dc.subject | Biochemical markers |
dc.subject | Drugs |
dc.title | CD69 expression potentially predicts response to bendamustine and its modulation by ibrutinib or idelalisib enhances cytotoxic effect in chronic lymphocytic leukemia |
dc.type | info:eu-repo/semantics/article |
dc.type | info:eu-repo/semantics/publishedVersion |
dc.description.abstract |